Evaluation of the potential endogenous interference from heterophilic antibodies, e.g. human anti-mouse antibody (HAMA) and rheumatoid factor, together with specific interfering substances (hemolysate, lipids and bilirubin) is performed during the validation of each panel, please view our Data Validation documents in the Document Download Center. No significant assay interference has been observed.